Skip to main content
Premium Trial:

Request an Annual Quote

Other Uses

The mRNA vaccine technology behind some of the authorized SARS-CoV-2 vaccines is also being applied to other diseases, including cancer, CBS Sunday Morning reports.

"We've had an incredible year using messenger RNA to fight a pandemic," Stephen Hoge, the president of Moderna, tells it. "But we think we're just starting in the infectious disease space. And so, there's a large number of other vaccines we're bringing forward."

As CBS Sunday Morning notes, the company is pursuing a vaccine for HIV, aims to streamline the process for making influenza vaccines, and is also developing vaccines for cancers like lymphoma and melanoma. One, for melanoma, is in clinical testing, it adds. BioNTech, which worked with Pfizer on their mRNA-based SARS-CoV-2 vaccine, is similarly seeking to expand its repertoire and is working on a tuberculosis and an HIV vaccine, as the Financial Times noted earlier this month.

At the same time, Moderna is also working on SARS-CoV-2 boosters, which CBS Sunday Morning says it is considering – if boosters are indeed needed – rolling that together with its flu vaccine so that people only need one shot.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.